Show simple item record

dc.contributor.authorUnceta Zaballa, Nora ORCID
dc.contributor.authorEcheazarra Escudero, Leire
dc.contributor.authorMontaña, Mario
dc.contributor.authorSallés Alvira, Joan
dc.contributor.authorGómez Caballero, Alberto
dc.contributor.authorGoicolea Altuna, María Aranzazu ORCID
dc.contributor.authorBarrio Díez-Caballero, Ramón José
dc.date.accessioned2024-02-08T10:03:13Z
dc.date.available2024-02-08T10:03:13Z
dc.date.issued2012-105-10
dc.identifier.citationJournal of Pharmaceutical and Biomedical Analysis 70 : 529-533 (2012)es_ES
dc.identifier.issn0731-7085
dc.identifier.issn1873-264X
dc.identifier.urihttp://hdl.handle.net/10810/65196
dc.description.abstractThis work proposes a liquid chromatography-electrospray ionization ion trap mass spectrometry (LC-ESI-ITMS) method, for the quantification of sildenafil (SDF), tadalafil (TDF) and vardenafil (VDF) and their metabolites N-desmethylSDF, O-desethylSDF and N-desethylVDF, preceded by a sample preparation step based on protein and phospholipid elimination. A C8 column (150 mm × 4.6 mm, 5 μm) with ammonium formate (20mM) and acetonitrile as the mobile phase components have been used. This method has been validated, obtaining limits of quantification ranged from 1 to 2.5 ng/mL and 2 to 5 ng/g in serum and brain tissue respectively, while limits of detection ranged from 0.3 to 0.9 ng/mL in serum and 0.6 to 1.9 ng/g in brain tissue. Assay recoveries for low level QC samples were higher than 83% and the matrix effect ranged between 91% and 108% in serum and between 98% and 107% in brain tissue. The method has been applied to the quantification of these compounds in the serum and brain tissue of rats treated intraperitoneally with 10 mg/kg of SDF, TDF or VDF.es_ES
dc.description.sponsorshipThis work was supported by the Spanish Minister of Science Innovation (Project CTQ2008-00651/BQU) and by grants from Basque Government (IT-332-10) and the Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM. Technical and human support provided by the Central Service of Analysis of Alava, SGIker (UPV/EHU, MICINN, GV/EJ, ESF) is gratefully acknowledged.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/CTQ2008-00651/BQU
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectphosphodiesterase-5 inhibitorses_ES
dc.subjectmetabolites
dc.subjectLC–ESI-ITMS
dc.subjectrat serum
dc.subjectrat brain tissue
dc.titleValidation of an LC-ESI-MS/MS for the quantitation of phosphodiesterase-5 inhibitors and their main metabolites in rat serum and brain tissue samples.es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2012 Elsevier under CC BY-NC-ND license
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0731708512002270
dc.identifier.doi10.1016/j.jpba.2012.04.030
dc.departamentoesFarmacologíaes_ES
dc.departamentoesQuímica analíticaes_ES
dc.departamentoeuFarmakologiaes_ES
dc.departamentoeuKimika analitikoaes_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2012 Elsevier under CC BY-NC-ND license
Except where otherwise noted, this item's license is described as © 2012 Elsevier under CC BY-NC-ND license